Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23957)

• Formulation Name: Dapagliflozin Propanediol 5mg tablet
• Company: Astrazeneca Ab

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Dapagliflozin	(DM28UJG)	Non-insulin dependent diabetes	5A11	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Cellulose microcrystalline	(E00698)	Not Available	Adsorbent; Suspending agent; Diluent
Colcothar yellow	(E00436)	518696	Colorant
Crospovidone	(E00626)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 4000	(E00654)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polyvinyl alcohol	(E00666)	Not Available	Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent